Urology CME

Credits: 0.50 CME / NCPD / CPE
Purdue University College of Pharmacy
Analyzing the Pros and Cons of Standard and Alternative Dosing Regimens of Immunotherapies and Combinations in Modern Oncology Practice
Evan J. Lipson, MD
May 11, 2021
Credits: 1.50 CME / MOC / CC
Medical Learning Institute, Inc.
Target Practice: Understanding How PARP Inhibitors Take Aim at DNA Damage Response Mutations Across Solid Tumors
Susana Banerjee, MBBS, MA, FRCP, PhD
May 7, 2021
Credits: 1.00 CME / MOC
Penn State College of Medicine
The Therapeutic Transformation of Bladder Cancer: Understanding Immune-, Targeted-, and Antibody-Based Models for Patient Care
Matthew D. Galsky, MD
April 20, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Making the Right Moves in the Evolving Prostate Cancer Therapeutic Landscape: Expert Guidance on Treatment Sequencing and Selection for Effective Management Across the Disease Continuum
Robert Dreicer, MD, MS, MACP, FASCO
March 3, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Examining the State of the Science on New Therapies in Bladder Cancer: Perspectives on the Latest Developments Across the Disease Continuum
Professor Thomas Powles, MBBS, MRCP, MD
March 3, 2021
Credits: 0.70 CME
Purdue University
Changing the Treatment Story With Hormonal Therapy in Prostate Cancer: Challenges and Opportunities for Improving Care Across Disease Settings
Neal D. Shore, MD, FACS
December 30, 2020
Credits: 1.00 CME / MOC
Penn State College of Medicine
Understanding the Evolving Treatment Landscape in Prostate Cancer: How to Leverage the Latest Advances and Strategies to Optimize Patient Outcomes
William K. Oh, MD
December 22, 2020
Credits: 1.00 CME / MOC
Penn State College of Medicine
Evidence and Insights on Innovative Treatment for Bladder Cancer: Clinical Breakthroughs From Targeted and Immune Options to Antibodies and Gene Therapy
Arjun Balar, MD
July 27, 2020
Credits: 1.00 CME
Medical Learning Institute, Inc.
Targeting DNA Repair Defects Through PARP Inhibition in Prostate Cancer: Rationale, Evidence, and Clinical Implications
Emmanuel S. Antonarakis, MD
July 22, 2020
Credits: 1.00 CME / MOC
Penn State College of Medicine
How I Think, How I Treat: Learning to Navigate the Modern Prostate Cancer Landscape
William K. Oh, MD
July 8, 2020
Credits: 0.50 CME / MOC
Penn State College of Medicine
Chair’s Take on Innovation in Prostate Cancer: Thoughts on New Evidence
William K. Oh, MD
June 22, 2020
Credits: 0.50 CME / MOC
Penn State College of Medicine
Innovative Treatments for Bladder Cancer: Thoughts From the Chair
Arjun Balar, MD
June 22, 2020
Purdue University College of Pharmacy
Mapping the Pathways to Better Patient Outcomes in Prostate Cancer: Personal Insights and Guidance From the Patient CaseBook
William K. Oh, MD
March 18, 2020
Penn State College of Medicine
Raising the Bar With Innovative Therapy for Bladder Cancer: Insights on Clinical Decision-Making in the New Era of Care
Arjun Balar, MD
March 17, 2020
Penn State College of Medicine
Advancing Bladder Cancer Care With Novel Therapeutics: Where We Are Headed With Immunotherapy, Targeted, and Antibody Options
Arjun Balar, MD
March 10, 2020

Education Collections